miRNA-155 upregulation and complement factor H deficits in Down’s syndrome
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Down's syndrome, a congenital disorder associated with cognitive impairment and early-onset Alzheimer's disease, is a progressive genetic pathology resulting from full or partial triplication of chromosome 21. Down's syndrome brain is typified by activated microglia, increases in inflammatory signaling, and an aberrant immune system. In these studies, a screening of micro-RNA (miRNA) from Down's syndrome brain and peripheral tissues indicated an upregulation of a chromosome 21-encoded miRNA-155 and a decrease in the abundance of the miRNA-155 mRNA target complement factor H (CFH), an important repressor of the innate immune response. Stressed primary human neuronal-glial cells indicated both miRNA-155 increase and CFH downregulation, an effect that was reversed using anti-miRNA-155. These findings suggest that immunopathological deficits associated with Down's syndrome can, in part, be explained by a generalized miRNA-155-mediated downregulation of CFH that may contribute to both brain and systemic immune pathology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mammalian microRNAs predominantly act to decrease target mRNA levels
Guo, H., Ingolia, N. T., Weissman, J. S., & Bartel, D. P. (2010) · Nature · doi:10.1038/nature09267 · Cited by 3,886 · cited 3×
“In fact, ribosome profiling has shown that up-regulated miRNAs act predominantly to decrease their target mRNA levels, and miRNA-mediated destabilization of mRNAs is the main reason for reductions in gene expression [10].”
Infections and immunodeficiency in Down syndrome
Ram, G., & Chinen, J. (2011) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2011.04335.x · Cited by 465
Lukiw, W. J., Zhao, Y., & Cui, J. G. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805371200 · Cited by 441
Self-citationSethi, P., & Lukiw, W. J. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.04.052 · Cited by 409
Self-citationInflammation and neurodegenerative diseases
Griffin, W. S. T. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.2.470s · Cited by 351
Aït Yahya-Graison, E., Aubert, J., Dauphinot, L., Rivals, I., Prieur, M., Golfier, G., Rossier, J., Personnaz, L., Créau, N., Bléhaut, H., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/520000 · Cited by 338 · cited 5×
“genetic evidence suggests that the Down’s phenotype is most likely multi-genetic, and only a specific subset of the 300 or so trisomic genes, interacting with other disomic genes, mediates disease onset [4,5].”
InfluentialCui, J. G., Li, Y. Y., Zhao, Y., Bhattacharjee, S., & Lukiw, W. J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.178848 · Cited by 274
Self-citationLukiw, W. J., Percy, M. E., & Kruck, T. P. (2005) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2005.04.021 · Cited by 140
Self-citationHSV-1 infection of human brain cells induces miRNA-146a and alzheimer-type inflammatory signaling.
Hill, J. M., Zhao, Y., Clement, C., Neumann, D. M., & Lukiw, W. J. (2009) · NeuroReport · doi:10.1097/wnr.0b013e3283329c05 · Cited by 130
Self-citationPerluigi, M., di Domenico, F., Fiorini, A., Cocciolo, A., Giorgi, A., Foppoli, C., Butterfield, D. A., Giorlandino, M., Giorlandino, C., Eugenia Schininà, M., et al. (2011) · PROTEOMICS – Clinical Applications · doi:10.1002/prca.201000121 · Cited by 97 · cited 4×
“This elevation may be due to inter-genetic or epigenetic effects; alternately, miRNA-155 is under the regulatory control of the transcription factor NF-κB which is also up-regulated in Down’s tissues [7,21–25].”
Influential
Cited by
Regulation of the MIR155 host gene in physiological and pathological processes
Elton, T. S., Selemon, H., Elton, S. M., & Parinandi, N. L. (2013) · Gene · doi:10.1016/j.gene.2012.12.009 · Cited by 393
(2012) · PubMed Central · Cited by 150
Immune Dysregulation in Children With Down Syndrome
Huggard, D., Doherty, D. G., & Molloy, E. J. (2020) · Frontiers in Pediatrics · doi:10.3389/fped.2020.00073 · Cited by 144
“significantly increased in DS, and this causes a significant downregulation of CFHmRNAwhichmay partly explain the increased prevalence of chronic inflammation and autoimmunity in this population (71).”
BackgroundRegulation of Complement Factor H (CFH) by Multiple miRNAs in Alzheimer’s Disease (AD) Brain
Lukiw, W. J., & Alexandrov, P. N. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8234-4 · Cited by 130
Self-citationPareek, S., Roy, S., Kumari, B., Jain, P., Banerjee, A., & Vrati, S. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-97 · Cited by 121
“Moreover, miR155 and miR-146a not only modulate Toll-like receptors (TLRs)-mediated innate immune response, but also target complement regulatory proteins and facilitate complement activation [17-19].”
Background
Metadata
- Authors
- Li, Y. Y., Alexandrov, P. N., Pogue, A. I., Zhao, Y., Bhattacharjee, S., & Lukiw, W. J.
- Venue
- NeuroReport
- Published
- 2012-02-15
- Volume
- 23
- Issue
- 3
- Pages
- 168-173
- ISSN
- 0959-4965 (ISSN-L)
- OpenAlex
- W2008408964
- Cited by
- 76
- References
- 10
- FWCI
- 4.70
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: miRNA-155 upregulation and complement factor H deficits in Down’s syndrome. https://app.cochat.ai/papers/10.1097/wnr.0b013e32834f4eb4
- The paper
- Li, Y. Y., Alexandrov, P. N., Pogue, A. I., Zhao, Y., Bhattacharjee, S., & Lukiw, W. J. (2012). miRNA-155 upregulation and complement factor H deficits in Down’s syndrome. NeuroReport. https://doi.org/10.1097/wnr.0b013e32834f4eb4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.